|
||
---|---|---|
Moderator 主持人 | Jianjun Li 李建军, Wenling Zhu 朱文玲, Baoqi Jiang 蒋宝琦, Luhua Shen 沈潞华, Guo’an Zhao 赵国安 | |
1:30 PM- |
Latest Advances in Atherosclerosis Mechanism Research 动脉粥样硬化机制研究最新进展 |
Yun Zhang 张运 |
1:50 PM- |
Current Evidence and Clinical Intervention of ASCVD Induced by Lp(a) Lp(a)致ASCVD的现有证据与临床干预 |
Jianjun Li 李建军 |
2:10 PM- |
Anticoagulation Therapy in Elderly Patients 老年患者的抗凝治疗 |
Meilin Liu 刘梅林 |
2:30 PM- |
Bleeding after Emergency PCI: How to Adjust Antithrombotic Medications 急诊PCI术后合并出血:如何调整抗栓药物 |
Jinqing Yuan 袁晋青 |
2:45 PM- |
What Are the Differences between New Oral Anticoagulants? 新型口服抗凝药有何区别? |
Xiangjun Yang 杨向军 |
3:00 PM- |
Prevention and Treatment of Coronary Microvascular Dysfunction during Perioperative Period of PCI 高度关注冠心病介入围手术期冠状动脉微血管功能障碍的防治 |
Dingyin Zeng 曾定尹 |
3:15 PM- |
Panel Discussion with Audience Q&A 专家讨论及听众问答 |
|
||
---|---|---|
Moderator 主持人 | Meilin Liu 刘梅林, Changcong Cui 崔长琮, Yi An 安毅, Junyu Cui 崔俊玉, Dongmei Wang 王冬梅 | |
3:30 PM- |
Clinical Adaptation Population and Future Prospect of PCSK9 Inhibitors PCSK9抑制剂的临床适应人群与未来展望 |
Jianjun Li 李建军 |
3:45 PM- |
Is Metformin Contraindicated in Acute Coronary Syndrome? 二甲双胍在急性冠脉综合征是否存在禁忌 |
Wenxian Liu 刘文娴 |
4:00 PM- |
Interpretation of the Chinese Expert Consensus on Heparin-Induced Thrombocytopenia 《肝素诱导血小板减少症中国专家共识》解读 |
Xin Zhao 赵昕 |
4:15 PM- |
Interpretation of 2018 ESC Guidelines on Cardiovascular Disease Management during Pregnancy 2018 ESC妊娠期心血管疾病管理指南解读 |
Xianyang Zhu 朱鲜阳 |
4:30 PM- |
Heart Rehabilitation: Don’t Let Women Left Behind 心脏康复:不要让女性掉队 |
Shujuan Cheng 程姝娟 |
4:45 PM- |
Panel Discussion with Audience Q&A 专家讨论及听众问答 |
|
5:00 PM- |
Adjourn 休会 |